Newswise
forgotten login
how to register

© Newswise.
All Rights Reserved.

Source: University of Alabama at Birmingham 

University of Alabama at Birmingham
  Released: Fri 12-Jun-2009, 13:00 ET 
Printer-friendly Version 

Chronic Infection Now Clearly Tied to Immune-System Protein

Libraries
Medical News
 Keywords
MICROBIOLOGY, VIROLOGY, AIDS/HIV, HEPATITIS, IMMUNOLOGY, INTERLEUKIN-21, CD8 T-CELLS, CD8 T-CELLS

Contact Information

Available for logged-in reporters only

Description

A new study finds the cross-talk between ‘killer T-cells’ and ‘helper T-cells’ can only happen in the presence of interleukin-21, a powerful immune-system protein. Researchers said if interleukin-21, or IL-21, is missing, then the body's own anti-viral efforts fail. The study mice were treated for lymphocytic choriomeningitis.


Video
UAB's Allan Zajac, Ph.D., talks about IL-21 and chronic infection
(01:37)
  Click screen to begin playback  
  Video/Audio requires the free QuickTime plugin.
Download it here.

Newswise — The reason deadly infections like human immunodeficiency virus (HIV) and hepatitis C never go away is because these viruses disarm the body’s defense system. Researchers at the University of Alabama at Birmingham (UAB) have discovered that a key immunity protein must be present for this defense system to have a chance against chronic infection.

Research up to now has tried but failed to decipher the cross-talk between ‘killer T-cells’ and ‘helper T-cells’ in the fight against viruses. The new UAB study finds this cross-talk can only happen in the presence of interleukin-21, a powerful immune system protein. If interleukin-21 is missing for whatever reason, then the immune system’s anti-viral efforts fail, said Allan Zajac, Ph.D., an associate professor in UAB's Department of Microbiology and lead author on the study.

The findings are published in the journal Science.

“Adding interleukin-21 back in stimulates the immune response and controls the infection,” Zajac said. “We demonstrate that the loss of this protein prevents the control of the infection and diminishes the function of the killer T-cells, specifically CD8 T-cells.”

The study mice were treated for lymphocytic choriomeningitis, a viral infection of the membranes surrounding the brain and spinal cord. Measurements were taken for two types of T-cells, CD4 and CD8 T-cells, before and after the mice were treated with interleuikin-21.

“Interleukin-21 served as the key messenger between the T-cells, whereas before we didn’t know exactly how the two types of cells communicated with each other,” Zajac said. The CD4 T-cells help the immune system do its job by boosting CD8 T-cells’ ability to fight and kill viruses.

Co-authors on the study include John Yi and Ming Du, Ph.D., both of UAB’s Department of Microbiology. Research funds came from the National Institutes of Health.